Noriaki Murao
Short Term Consultant, World Health Organization, Western Pacific Region
DIA Fellow
Q&A
In your opinion, what is the greatest challenge in your field?
The development and implementation of pharmaceutical legislation in emerging countries.
What in your opinion is the biggest gap between research and practice in your field?
With new drug development, the probability of success for commercialization is extremely low.
What do you like most and least about your job?
I am currently working at the Department of Health and Social Affairs in the Federated States of Micronesia, which is a small and poor country (only 100,000 population) in the Pacific Ocean. A hot topic is substandard and counterfeit medicines in Asian and Pacific Island countries. I would like to work on how we can eliminate such medicines in these countries.
What book are you currently reading and why?
I am currently reading a book about the history of WWII in the Pacific Ocean.
What advice would you give your younger self about to enter the "real world?"
In our generation, you could survive if you became an expert in one area only, but today you should become an expert in multiple areas because job opportunities will be varied time by time.
Imagine a day without work, the internet, and any other obligations. What would you do?
I would cook my favorite dishes and invite my good friends for dinner.
How has DIA helped you?
I obviously enjoy networking and obtaining updates and hot information.
BIOGRAPHY
Noriaki Murao is an independent regulatory consultant who spent four decades working in new drug development in national and global companies such as Otsuka Pharmaceutical Co. Ltd. and Aventis. While conducting clinical research in Germany, he was invited to the DIA EuroMeeting and to serve on the DIA Steering Committee for Europe. These experiences helped support the growth of DIA Japan upon his return: He served as speaker, chairperson, and on the program committee for numerous DIA Japan meetings, and has contributed as a chairperson and speaker to the DIA EuroMeeting and Global Annual Meeting. In 2015, Murao was recognized as a Fellow of DIA. He earned his BS and MS degrees in Pharmacy from Fukuoka University and Kyushu University.
DIA Spotlights
-
Jonathan Andrus • Chief Business Officer, Clinical Ink
DIA Inspire Award Winner -
Catherine Baldridge • Principal Consultant & Owner, Essential Pharmacovigilance, LLC
DIA Community Leadership Council -
Kimberly Belsky • Executive Director, Regulatory Policy & Intelligence, Mallinckrodt Pharmaceuticals
DIA AdPromo Working Group Chair, DIA Regulatory Affairs Community -
Megan Bettle • Director, Centre for Regulatory Excellence, Statistics and Trials
Regional Editor Global Forum -
Stella Blackburn • Vice President, Global Head of Early Access and Risk Management, IQVIA
DIA Volunteer -
Poonam Bordoloi • Medical Affairs Team Lead, General Medicines, Global Scientific Content, Merck & Co., Inc.
DIA Volunteer -
Linda Bowen • Head of Regulatory Policy and Intelligence, Seattle Genetics; Assistant Professor, RAQA Program, Temple University
DIA Inspire Award Winner -
Joan Buenconsejo • Director and Biometrics Team Leader, Astra Zeneca
DIA Statistics Community Chair -
Gerald Dal Pan • Director, Office of Surveillance & Epidemiology, FDA’s Center for Drug Evaluation and Research
DIA Fellow -
Gaby Danan • former EU QPPV, Sanofi
DIA Fellow -
Richard Day • Professor of Clinical Pharmacology; University of New South Wales, Medicine, St. Vincent's Hospital
Fellow of DIA
Associate Editor TIRS
Regional Editor Global Forum -
Nancy Dreyer • Chief Scientific Officer and Senior Vice President, IQVIA
Fellow of DIA
DIA Inspire Award Winner -
E. Stewart Geary • Chief Medical Officer and a Senior Vice President, Eisai Co., Ltd.
DIA Fellow -
Alberto Grignolo • Corporate Vice President, Parexel
Fellow of DIA
Editor-in-Chief Global Forum -
Terry Katz • Head, Data Management and Statistics, Merck Animal Health
DIA GCP-QA Community Chair -
Agnes Klein • Senior Medical Advisor, Biologic and Radiopharmaceutical Drugs Directorate, Health Canada
DIA Volunteer -
Mark Kryah • Senior Advisor and COO, Pharmaceutical Project Management, Immunology, Eli Lilly and Company
DIA Project Management Community Chair -
Birka Lehmann • Senior Expert, Drug Regulatory Affairs; Lecturer, Friedrich Wilhelm University
Fellow of DIA -
Munish Mehra • Principal Biostatistician & Executive Director, Tigermed
DIA Inspire Award Winner
DIA Clinical Research Community Chair -
Lisa Mulcahy • Owner and Principal Consultant, Mulcahy Consulting, LLC
DIA Document and Records Management Community Chair -
Noriaki Murao • Short Term Consultant, World Health Organization, Western Pacific Region
DIA Fellow -
Robert Paarlberg • Principal, Paarlberg & Associates LLC
DIA Inspire Award Winner -
Kim Quaintance-Lunn • Vice President and Head, Regulatory Policy, North American Regulatory Affairs, Bayer
DIA Inspire Award Winner -
Matthew Reaney • Scientific Lead, Patient Centered Endpoints, IQVIA
DIA Study Endpoints Community Chair -
Jeffrey Sherman • Chief Medical Officer and Executive Vice President, Horizon Therapeutics
Fellow of DIA -
Meredith Smith • Director, Risk Management, Alexion Pharmaceuticals, Inc.; Adjunct Professor, School of Pharmacy, University of Southern California, Los Angeles
DIA Volunteer -
Ling Su • Professor and Director, Institute of Drug Regulatory Science, Shenyang Pharmaceutical University; Venture Partner, Lilly Asia Ventures
Fellow of DIA -
Angela van der Salm • Director Pharmacovigilance, Managing Partner, DADA Consultancy
DIA Volunteer -
Casey Walker • PGY-1 Behavioral Health Pharmacy Resident, University of the Sciences of Philadelphia
DIA Inspire Award Winner -
Jingsong Wang • CEO, Harbour BioMed
DIA Inspire Award Winner -
Richard C. Zink • Senior Director, Data Management and Statistics, TARGET PharmaSolutions
Associate Editor Therapeutic Innovation & Regulatory Science